Nifty 50
Tools & Calculators
Stocks
F&O
Mutual Funds
Sector: Pharmaceuticals & Biotechnology
|Small Cap
GUJTHEM
₹369.55
₹362.10
₹371.80
₹225.05
₹479.00
Markets Today
Historical Performance
As of 17-07-2026 12:08, Gujarat Themis Biosyn Ltd. share price today is ₹0, with a change of ₹-370.40 (-100.00%) from the previous close of ₹370.4. The stock opened at ₹370.3 and traded between ₹362.1 and ₹371.8, with a total traded volume of 68166 shares. The company has a market capitalization of ₹4036.1 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹479 and ₹225.05, respectively.
Gujarat Themis Biosyn Ltd. valuation metrics include a P/E ratio of 86.5, and book value of ₹14.00. Profitability indicators show ROE of 16.22% along with a dividend yield of 0.2%. Gujarat Themis Biosyn Ltd. has reported revenue of ₹165.82 Cr and net profit of ₹46.68 Cr.
Gujarat Themis Biosyn Ltd. technical indicators include Day RSI at 43.59, Day MFI at 49.05, Day ADX at 14.43. Additional indicators include Commodity Channel Index (CCI) at -99.2 and Williams %R at -83.81. Momentum indicators show Day MACD at -3.16, Day MACD Signal Line at -0.74, DayATR at 16.3. Rate of Change indicators for Gujarat Themis Biosyn Ltd. include ROC125 at -5.23 and ROC21 at -2.17.
Exponential moving averages include EMA5 at ₹373.6, EMA10 at ₹377.1, EMA12 at ₹378.3, EMA20 at ₹381.1, EMA26 at ₹381.4, EMA50 at ₹375.6, EMA100 at ₹365.5, EMA200 at ₹355.6. Simple moving averages include SMA5 at ₹375, SMA10 at ₹376.4, SMA20 at ₹384.6, SMA30 at ₹387.2, SMA50 at ₹384.7, SMA100 at ₹344.1, SMA150 at ₹353, SMA200 at ₹372.2.
Support levels for Gujarat Themis are placed at First Support ₹365.18, Second Support ₹359.97, Third Support ₹353.88. Resistance levels are seen at First Resistance ₹376.48, Second Resistance ₹382.57, Third Resistance ₹387.78. Gujarat Themis Biosyn Ltd. shareholding pattern shows promoter holding at 70.86%, FII holding at 1.8%, DII holding at 0%, public holding at 26.15%.
Indicator | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| Total Revenue | 44.23 | 43.37 | 42.35 | 35.87 | 37.74 |
| Operating Expense | 24.87 | 22.06 | 21.41 | 21.95 | 21.70 |
| Operating Profit | 19.36 | 21.31 | 20.94 | 13.92 | 16.04 |
| Depreciation | 4.04 | 3.89 | 2.96 | 2.03 | 1.23 |
| Interest | 1.91 | 0.96 | 0.04 | 0.04 | 0.07 |
| Tax | 3.45 | 4.41 | 4.50 | 3.06 | 4.09 |
| Net Profit | 10.89 | 12.46 | 14.26 | 9.06 | 12 |
₹369.55
↗ Bullish Moving Average
4
↘ Bearish Moving Average
12
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoter | 70.9 | 70.9 | 70.9 | 70.9 | 70.9 | 70.9 |
| FII | 1.4 | 1.9 | 2.5 | 3 | 2 | 1.8 |
| DII | 1.2 | 1.2 | 1.2 | 1.1 | 1.1 | 1.2 |
| Public | 26.6 | 26 | 25.4 | 25 | 26 | 26.2 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 27.87 K | 59.71 K | 46.68% |
| Week | 57.76 K | 1 L | 57.58% |
| 1 Month | 90.36 K | 1.54 L | 58.59% |
| 6 Month | 79.35 K | 2.44 L | 32.51% |
Benjamin Graham Value Screen
Expensive Performers (DVM)
PEG lower than Industry PEG
Increasing Revenue every quarter for the past 3 quarters
Stocks Outperforming their Industry Price Change in the Quarter
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 04 Sep, 2025 | 0.67 | FINAL | 05 Sep, 2025 | Equity Share |
| 15 Jul, 2024 | 0.25 | FINAL | Equity Share | |
| 22 Feb, 2024 | 0.75 | INTERIM | 22 Feb, 2024 | Equity Share |
| 01 Sep, 2023 | 1 | FINAL | Equity Share | |
| 01 Dec, 2022 | 4.4 | INTERIM | 02 Dec, 2022 | Equity Share |
| 29 Aug, 2022 | 4 | FINAL | Equity Share | |
| 24 Nov, 2021 | 2 | INTERIM | 25 Nov, 2021 | Equity Share |
| 24 Nov, 2021 | 5 | SPECIAL | 25 Nov, 2021 | Equity Share |
| 10 Sep, 2020 | 1.65 | FINAL | Equity Share |
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹555.30 | ₹5.24 | ₹168 | ₹14.75 | ₹538.50 | ₹63.89 |
| % Change | -2.70% | 3.15% | 1.65% | -2.83% | 0.72% | 0.46% |
| Revenue TTM (₹ Cr) | - | ₹83.60 | ₹287.68 | ₹176.50 | ₹502.55 | ₹237.47 |
| Net Profit TTM (₹ Cr) | - | ₹-34.95 | ₹14.88 | ₹27.81 | ₹57.92 | ₹-3.28 |
| PE TTM | - | -1.20 | 43.10 | 29.00 | 26.70 | -105.40 |
| 1 Year Return | 45.59 | 408 | 31.17 | 66.81 | -24.39 | -43.13 |
| ROCE | 3.56 | -5.63 | - | 17.36 | 23.87 | 0.77 |
Sigachi Industries Ltd.
₹ 25.02
+2.00%
Windlas Biotech Ltd.
₹ 842.10
-0.96%
Vineet Laboratories Ltd.
₹ 37.38
-1.76%
Solara Active Pharma Sciences Ltd.
₹ 572.25
-1.00%
Zim Laboratories Ltd.
₹ 121.00
-1.60%
Medico Remedies Ltd.
₹ 39.20
+0.85%
Dishman Carbogen Amcis Ltd.
₹ 192.25
-0.96%
Lasa Supergenerics Ltd.
₹ 7.39
+1.23%
Advanced Enzyme Technologies Ltd.
₹ 322.00
-0.94%
Bajaj Healthcare Ltd.
₹ 373.15
+0.07%
Ortin Global Ltd.
₹ 15.50
-1.52%
Brooks Laboratories Ltd.
₹ 68.53
-1.81%
RPG Life Sciences Ltd.
₹ 2842.50
-2.72%
Bafna Pharmaceuticals Ltd.
₹ 225.88
+2.00%
Alpa Laboratories Ltd.
₹ 68.12
-1.13%
SMS Pharmaceuticals Ltd.
₹ 385.00
-0.54%
Nectar Lifesciences Ltd.
₹ 10.85
-0.46%
Mangalam Drugs and Organics Ltd.
₹ 27.72
+1.20%
Indoco Remedies Ltd.
₹ 245.10
-2.70%
Ind-Swift Laboratories Ltd.
₹ 229.25
-1.98%
Lincoln Pharmaceuticals Ltd.
₹ 599.00
-0.46%
Panacea Biotec Ltd.
₹ 546.80
-3.04%
Medicamen Biotech Ltd.
₹ 237.10
-0.59%
Themis Medicare Ltd.
₹ 109.99
-2.16%
By signing up I certify terms, conditions & privacy policy